Loading…
Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab
Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab. Methods: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant. Discuss...
Saved in:
| Published in: | Ocular immunology and inflammation 2016-01, Vol.24 (1), p.118-119 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723 |
| container_end_page | 119 |
| container_issue | 1 |
| container_start_page | 118 |
| container_title | Ocular immunology and inflammation |
| container_volume | 24 |
| creator | Damasceno, Nadyr P. Horowitz, Soraya A. Damasceno, Eduardo F. |
| description | Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.
Methods: After searching for extensive laboratory tests to isolate the etiologic agent
Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.
Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen. |
| doi_str_mv | 10.3109/09273948.2014.898073 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_09273948_2014_898073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1787958234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMobn78A5FeetOZNOmSXImM-QEDRfQ6JO0pZrTJTFJl_npbNr306sDhed8XHoQuCJ5RguU1lgWnkolZgQmbCSkwpwdoSjhjeYm5OETTEclHZoJOYlxjjJmU5BhNCsaZnJdsil5X0Ffe-Zh8lemY6Wyh-wiZb7Klq_3mPb3rtrPJxux5gHLrUtCfNgXQbfbo1lAl692Iv2hnjf3uO23O0FGj2wjn-3uK3u6Wr4uHfPV0_7i4XeUVozTlMJe1IXUBVUEZYCj5vDFcEuCU12IugRkMAiippSk4gDGNKenwl4YywQt6iq52vZvgP3qISXU2VtC22oHvoyJccFmKoX1A2Q6tgo8xQKM2wXY6bBXBavSpfn2q0afa-Rxil_uF3nRQ_4V-BQ7AzQ6wrvGh018-tLVKetv60ATtKhvH-n8mfgD7MIVa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787958234</pqid></control><display><type>article</type><title>Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Damasceno, Nadyr P. ; Horowitz, Soraya A. ; Damasceno, Eduardo F.</creator><creatorcontrib>Damasceno, Nadyr P. ; Horowitz, Soraya A. ; Damasceno, Eduardo F.</creatorcontrib><description>Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.
Methods: After searching for extensive laboratory tests to isolate the etiologic agent
Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.
Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.</description><identifier>ISSN: 0927-3948</identifier><identifier>EISSN: 1744-5078</identifier><identifier>DOI: 10.3109/09273948.2014.898073</identifier><identifier>PMID: 24749654</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Aged, 80 and over ; Amikacin - therapeutic use ; Angiogenesis Inhibitors - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Complications ; endophthalmitis ; Endophthalmitis - diagnosis ; Endophthalmitis - drug therapy ; Endophthalmitis - microbiology ; Eye Infections, Bacterial - diagnosis ; Eye Infections, Bacterial - drug therapy ; Eye Infections, Bacterial - microbiology ; Gram-Positive Bacterial Infections - diagnosis ; Gram-Positive Bacterial Infections - drug therapy ; Gram-Positive Bacterial Infections - microbiology ; Humans ; Intravitreal Injections ; Leuconostoc ; Leuconostoc - isolation & purification ; Leuconostoc mesenteroides ; Leuconostocaceae ; Male ; opportunistic pathogens ; Postoperative Complications ; ranibizumab ; Ranibizumab - administration & dosage ; Vascular Endothelial Growth Factor A - antagonists & inhibitors ; Vitreous Body - microbiology ; Wet Macular Degeneration - drug therapy</subject><ispartof>Ocular immunology and inflammation, 2016-01, Vol.24 (1), p.118-119</ispartof><rights>2016 Taylor & Francis Group, LLC 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723</citedby><cites>FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24749654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Damasceno, Nadyr P.</creatorcontrib><creatorcontrib>Horowitz, Soraya A.</creatorcontrib><creatorcontrib>Damasceno, Eduardo F.</creatorcontrib><title>Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab</title><title>Ocular immunology and inflammation</title><addtitle>Ocul Immunol Inflamm</addtitle><description>Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.
Methods: After searching for extensive laboratory tests to isolate the etiologic agent
Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.
Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.</description><subject>Aged, 80 and over</subject><subject>Amikacin - therapeutic use</subject><subject>Angiogenesis Inhibitors - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Complications</subject><subject>endophthalmitis</subject><subject>Endophthalmitis - diagnosis</subject><subject>Endophthalmitis - drug therapy</subject><subject>Endophthalmitis - microbiology</subject><subject>Eye Infections, Bacterial - diagnosis</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Eye Infections, Bacterial - microbiology</subject><subject>Gram-Positive Bacterial Infections - diagnosis</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Gram-Positive Bacterial Infections - microbiology</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Leuconostoc</subject><subject>Leuconostoc - isolation & purification</subject><subject>Leuconostoc mesenteroides</subject><subject>Leuconostocaceae</subject><subject>Male</subject><subject>opportunistic pathogens</subject><subject>Postoperative Complications</subject><subject>ranibizumab</subject><subject>Ranibizumab - administration & dosage</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><subject>Vitreous Body - microbiology</subject><subject>Wet Macular Degeneration - drug therapy</subject><issn>0927-3948</issn><issn>1744-5078</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMobn78A5FeetOZNOmSXImM-QEDRfQ6JO0pZrTJTFJl_npbNr306sDhed8XHoQuCJ5RguU1lgWnkolZgQmbCSkwpwdoSjhjeYm5OETTEclHZoJOYlxjjJmU5BhNCsaZnJdsil5X0Ffe-Zh8lemY6Wyh-wiZb7Klq_3mPb3rtrPJxux5gHLrUtCfNgXQbfbo1lAl692Iv2hnjf3uO23O0FGj2wjn-3uK3u6Wr4uHfPV0_7i4XeUVozTlMJe1IXUBVUEZYCj5vDFcEuCU12IugRkMAiippSk4gDGNKenwl4YywQt6iq52vZvgP3qISXU2VtC22oHvoyJccFmKoX1A2Q6tgo8xQKM2wXY6bBXBavSpfn2q0afa-Rxil_uF3nRQ_4V-BQ7AzQ6wrvGh018-tLVKetv60ATtKhvH-n8mfgD7MIVa</recordid><startdate>20160102</startdate><enddate>20160102</enddate><creator>Damasceno, Nadyr P.</creator><creator>Horowitz, Soraya A.</creator><creator>Damasceno, Eduardo F.</creator><general>Informa Healthcare</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160102</creationdate><title>Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab</title><author>Damasceno, Nadyr P. ; Horowitz, Soraya A. ; Damasceno, Eduardo F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged, 80 and over</topic><topic>Amikacin - therapeutic use</topic><topic>Angiogenesis Inhibitors - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Complications</topic><topic>endophthalmitis</topic><topic>Endophthalmitis - diagnosis</topic><topic>Endophthalmitis - drug therapy</topic><topic>Endophthalmitis - microbiology</topic><topic>Eye Infections, Bacterial - diagnosis</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Eye Infections, Bacterial - microbiology</topic><topic>Gram-Positive Bacterial Infections - diagnosis</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Gram-Positive Bacterial Infections - microbiology</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Leuconostoc</topic><topic>Leuconostoc - isolation & purification</topic><topic>Leuconostoc mesenteroides</topic><topic>Leuconostocaceae</topic><topic>Male</topic><topic>opportunistic pathogens</topic><topic>Postoperative Complications</topic><topic>ranibizumab</topic><topic>Ranibizumab - administration & dosage</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><topic>Vitreous Body - microbiology</topic><topic>Wet Macular Degeneration - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Damasceno, Nadyr P.</creatorcontrib><creatorcontrib>Horowitz, Soraya A.</creatorcontrib><creatorcontrib>Damasceno, Eduardo F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Ocular immunology and inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Damasceno, Nadyr P.</au><au>Horowitz, Soraya A.</au><au>Damasceno, Eduardo F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab</atitle><jtitle>Ocular immunology and inflammation</jtitle><addtitle>Ocul Immunol Inflamm</addtitle><date>2016-01-02</date><risdate>2016</risdate><volume>24</volume><issue>1</issue><spage>118</spage><epage>119</epage><pages>118-119</pages><issn>0927-3948</issn><eissn>1744-5078</eissn><abstract>Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.
Methods: After searching for extensive laboratory tests to isolate the etiologic agent
Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.
Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>24749654</pmid><doi>10.3109/09273948.2014.898073</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0927-3948 |
| ispartof | Ocular immunology and inflammation, 2016-01, Vol.24 (1), p.118-119 |
| issn | 0927-3948 1744-5078 |
| language | eng |
| recordid | cdi_crossref_primary_10_3109_09273948_2014_898073 |
| source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
| subjects | Aged, 80 and over Amikacin - therapeutic use Angiogenesis Inhibitors - administration & dosage Anti-Bacterial Agents - therapeutic use Complications endophthalmitis Endophthalmitis - diagnosis Endophthalmitis - drug therapy Endophthalmitis - microbiology Eye Infections, Bacterial - diagnosis Eye Infections, Bacterial - drug therapy Eye Infections, Bacterial - microbiology Gram-Positive Bacterial Infections - diagnosis Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Humans Intravitreal Injections Leuconostoc Leuconostoc - isolation & purification Leuconostoc mesenteroides Leuconostocaceae Male opportunistic pathogens Postoperative Complications ranibizumab Ranibizumab - administration & dosage Vascular Endothelial Growth Factor A - antagonists & inhibitors Vitreous Body - microbiology Wet Macular Degeneration - drug therapy |
| title | Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leuconostoc%20as%20a%20Cause%20of%20Endophthalmitis%20Post-intravitreal%20Injection%20of%20Ranibizumab&rft.jtitle=Ocular%20immunology%20and%20inflammation&rft.au=Damasceno,%20Nadyr%20P.&rft.date=2016-01-02&rft.volume=24&rft.issue=1&rft.spage=118&rft.epage=119&rft.pages=118-119&rft.issn=0927-3948&rft.eissn=1744-5078&rft_id=info:doi/10.3109/09273948.2014.898073&rft_dat=%3Cproquest_cross%3E1787958234%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-e69db1d2ec234e0e576fb791e737d869e4b0e8e31d9b27eebbfb5369e9b348723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1787958234&rft_id=info:pmid/24749654&rfr_iscdi=true |